JPRN-UMIN000027374
Completed
Phase 2
Efficacy of Positron Emission Mammography in evaluating clinical response after preoperative chemotherapy - Efficacy of Positron Emission Mammography in evaluating clinical responce after preoperative chemotherapy
ConditionsBreast Cancer
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Breast Cancer
- Sponsor
- Aichi Cancer Center
- Enrollment
- 50
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Allergy with FDG Patients holding pacemaker Patients with pregnancy or breastfeeding Patients with diabetes Patients with difficult of taking PEM
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Efficacy of Positron Emission Mammography in decision of the surgery methodbreast cancerJPRN-UMIN000027412Aichi cancer center hospital190
Completed
Not Applicable
Comparison of Positron Emission Mammography and Contrast-enhanced Breast MRIBreast CancerNCT02770586Mayo Clinic50
Terminated
Not Applicable
Improving Diagnosis of Breast Cancer by Using a Combined MRI and Positron Emission Mammography (MRI-PEM) SystemBreast CancerNCT02426489Weinberg Medical Physics LLC1
Completed
Not Applicable
PET/CT or PET/MRI in Measuring Tumors in Patients Undergoing Clinical Imaging or With Newly Diagnosed Breast CancerBreast CancerUnspecified Adult Solid Tumor, Protocol SpecificNCT01892540Case Comprehensive Cancer Center43
Completed
Not Applicable
Positron Emission Mammography and Standard Mammography in Women at High Risk of Breast CancerBreast CancerNCT00896649Boston Medical Center193